novo nordisk glp-1 drugs Drops Hims & Hers: Inside the Compounded Crisis Lilly launches GLP-1 pill, kicking

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

Postprandial reduction in hunger was greater after RYGB than OAGB from baseline to 12 months

The 30-second spot was developed in-house.

Rybelsus is an effective treatment for Type 2 Diabetes

Blue Cross Blue Shield of Massachusetts will soon stop covering popular drugs for weight loss, like Ozempic.

FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs